Suppr超能文献

在马歇尔静脉内注入乙醇治疗持续性心房颤动的解剖学治疗策略——当前挑战与未来方向

Anatomical Treatment Strategies for Persistent Atrial Fibrillation with Ethanol Infusion within the Vein of Marshall-Current Challenges and Future Directions.

作者信息

Yokoyama Masaaki, Vlachos Konstantinos, Ogbedeh Chizute, Ascione Ciro, Kowalewski Christopher, Popa Miruna, Monaco Cinzia, Benali Karim, Kneizeh Kinan, Mené Roberto, Arnaud Marine, Buliard Samuel, Bouyer Benjamin, Tixier Romain, Chauvel Rémi, Duchateau Josselin, Pambrun Thomas, Sacher Frédéric, Hocini Mélèze, Haïssaguerre Michel, Jaïs Pierre, Derval Nicolas

机构信息

Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33604 Bordeaux-Pessac, France.

IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Université de Bordeaux, 33604 Bordeaux-Pessac, France.

出版信息

J Clin Med. 2024 Oct 3;13(19):5910. doi: 10.3390/jcm13195910.

Abstract

Currently, pulmonary vein isolation (PVI) is the gold standard in catheter ablation for atrial fibrillation (AF). However, PVI alone may be insufficient in the management of persistent AF, and complementary methods are being explored. One such method takes an anatomical approach-improving both its success rate and lesion durability may lead to improved treatment outcomes. An additional approach complementary to the anatomical one is also attracting attention, one that focuses on epicardial conduction. This involves ethanol ablation of the vein of Marshall (VOM) and can be very effective in blocking epicardial conduction related to Marshall structure; it is becoming incorporated into standard treatment. However, the pitfall of this "Marshall-PLAN", a method that combines an anatomical approach with ethanol infusion within the VOM (Et-VOM), is that Et-VOM and other line creations are not always successfully completed. This has led to cases of AF and/or atrial tachycardia (AT) recurrence even after completing this lesion set. Investigating effective adjunctive methods will enable us to complete the lesion set with the aim to lower the rates of recurrence of AF and/or AT in the future.

摘要

目前,肺静脉隔离(PVI)是心房颤动(AF)导管消融的金标准。然而,单纯的PVI在持续性AF的治疗中可能并不充分,目前正在探索补充方法。其中一种方法采用解剖学方法——提高其成功率和损伤耐久性可能会改善治疗效果。另一种与解剖学方法互补的方法也备受关注,即专注于心外膜传导的方法。这涉及到对Marshall静脉(VOM)进行乙醇消融,并且在阻断与Marshall结构相关的心外膜传导方面非常有效;它正被纳入标准治疗。然而,这种“Marshall-PLAN”方法存在缺陷,该方法将解剖学方法与在VOM内注入乙醇(Et-VOM)相结合,Et-VOM和其他线路创建并不总是能成功完成。这导致即使完成了该损伤组,仍有AF和/或房性心动过速(AT)复发的情况。研究有效的辅助方法将使我们能够完成损伤组,以期在未来降低AF和/或AT的复发率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ba/11477583/443f7ead7c10/jcm-13-05910-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验